This Wellness Company Just Landed the Biggest Extraction Deal With a Cannabis Company in Canada

The launch of marijuana edibles is fast approaching and Green Organic Dutchman Holdings Ltd (TSX:TGOD) is one company that looks to be a big player in that segment of the market.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

The cannabis industry is big business, and for companies that can take advantage of its strong growth, the potential could be significant. It’s why we’ve seen retailers and companies from other industries look to get involved and get a piece of the lucrative pie. With the industry still experience a lot of growth, it’s an attractive time for companies to secure agreements.

One company that looks to benefit from the growing industry is Neptune Wellness Solutions Inc (TSX:NEPT)(NASDAQ:NEPT), which announced last week that it had entered into a long-term extraction agreement with Green Organic Dutchman Holdings Ltd (TSX:TGOD). It’s a three-year deal that will see TGOD supply Neptune with 230,000 kilograms of cannabis and hemp to extract and convert into premium cannabis products, making it the largest such deal in Canada to date.

This is not the first time that Neptune has gotten involved with a cannabis company, as its price soared last year after it announced it had a deal with cannabis giant Canopy Growth Corp for an extraction deal as well. Earlier this month, it also secured a deal with Tilray.

Neptune is a great example of a company in a comparable industry that looks to take advantage of its existing competencies and strengths to position itself as a key partner for multiples cannabis companies.

These deals help to make Neptune front and centre for other cannabis companies looking for an extraction partner. It also doesn’t hurt that Neptune received rave reviews from TGOD’s CEO Brian Athaide, stating that “With this agreement, Neptune becomes a key partner for TGOD; we have been impressed with their commitment to innovation and excellence in every aspect of their business. Their unique capabilities in terms of extraction, formulation and packaging were decisive factors in our selection process.”

It’s expected that TGOD will send its first shipments to Neptune in September, months before edibles will be available for sale. The deal is a good one for both companies, and will help them grow their respective brands in the cannabis industry. TGOD has been eagerly awaiting the launch of edibles and it initially gained popularity in the industry last year when it announced it was licensing a proprietary infusing technology that would give it a big advantage in the market.

TGOD hasn’t achieved much sales over the past year, but once the edibles segment of the industry gets going, that could change in a hurry. Neptune is also hoping for edibles to improve its results and give the stock some life. The company released its quarterly earnings last week, and it already started to see some cannabis-related revenues trickle in.

Unfortunately, with the company recording a disappointing performance that saw both revenues and profits being significantly worse from a year ago, the stock went on to decline despite the news of the agreement with TGOD.

Year to date, Neptune is still up over 65% and there’s definitely a lot more room for the stock to rise as it benefits from its extraction agreements.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »

a person watches a downward arrow crash through the floor
Cannabis Stocks

Why Tilray Stock Fell Almost 60% in 2022

Tilray is a Canadian cannabis stock that is down 93% from all-time highs. Let's see if TLRY stock is a…

Read more »